Mostra i principali dati dell'item

dc.creatorAlexacou, K. M.en
dc.creatorZhang, Y. Z.en
dc.creatorPraly, J. P.en
dc.creatorZographos, S. E.en
dc.creatorChrysina, E. D.en
dc.creatorOikonomakos, N. G.en
dc.creatorLeonidas, D. D.en
dc.date.accessioned2015-11-23T10:21:56Z
dc.date.available2015-11-23T10:21:56Z
dc.date.issued2011
dc.identifier10.1016/j.bmc.2011.07.024
dc.identifier.issn0968-0896
dc.identifier.urihttp://hdl.handle.net/11615/25439
dc.description.abstractElectrophilic halogenation of C-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl) 1,4-dimethoxybenzene (1) afforded regioselectively products halogenated at the para position to the D-glucosyl moiety (8, 9) that were deacetylated to 3 (chloride) and 16 (bromide). For preparing meta regioisomers, 1 was efficiently oxidized with CAN to afford C-(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl) 1,4-benzoquinone 2 which, in either MeOH or H2O-THF containing few equivalents of AcCl, added hydrochloric acid to produce predominantly meta (with respect to the sugar moiety) chlorinated hydroquinone derivatives 5 and 18, this latter being deacetylated to 4. The deacetylated meta (4, 5) or para (3, 16) halohydroquinones were evaluated as inhibitors of glycogen phosphorylase (GP, a molecular target for inhibition of hepatic glycogenolysis under high glucose concentrations) by kinetics and X-ray crystallography. These compounds are competitive inhibitors of GPb with respect to alpha-D-glucose-1-phosphate. The measured IC50 values (mu M) [169.9 +/- 10.0 (3), 95 (4), 39.8 +/- 0.3 (5) 136.4 +/- 4.9 (16)] showed that the meta halogenated inhibitors (4, 5) are more potent than their para analogs (3, 16). The crystal structures of GPb in complex with these compounds at high resolution (1.97-2.05 angstrom) revealed that the inhibitors are accommodated at the catalytic site and stabilize the T conformation of the enzyme. The differences in their inhibitory potency can be interpreted in terms of variations in the interactions with protein residues of the different substituents on the aromatic part of the inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.en
dc.sourceBioorganic & Medicinal Chemistryen
dc.source.uri<Go to ISI>://WOS:000294002400005
dc.subjectType 2 diabetesen
dc.subjectGlycogen phosphorylaseen
dc.subjectC-glucosyl arylen
dc.subjectC-glucopyranosyl hydroquinoneen
dc.subjectInhibitionen
dc.subjectX-ray crystallographyen
dc.subjectTYPE-2 DIABETES THERAPYen
dc.subjectMOLECULAR GRAPHICSen
dc.subjectINHIBITOR DESIGNen
dc.subjectMELLITUSen
dc.subjectPHOSPHATEen
dc.subjectPROGRAMen
dc.subjectSEARCHen
dc.subjectMUSCLEen
dc.subjectMILDen
dc.subjectBiochemistry & Molecular Biologyen
dc.subjectChemistry, Medicinalen
dc.subjectChemistry,en
dc.subjectOrganicen
dc.titleHalogen-substituted (C-beta-D-glucopyranosyl)-hydroquinone regioisomers: Synthesis, enzymatic evaluation and their binding to glycogen phosphorylaseen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item